Advertisement

Topics

Latest "Biomarker discovery Driving technologies" News Stories

22:08 EDT 18th October 2017 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 18,000+

Relevant

Biomarkers technologies,markets and companies [Report Updated: 08092017] Prices from USD $5000

SummaryThis report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery...


Syros Presents Biomarker Data from its Mid-Stage Trial in Genomically Defined AML and MDS Patients

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company pioneering the discovery and development of medicines to control the expression of disease-driving genes, today announced that the biomarker status of patients screened for the ongoing Phase 2 clinical trial of SY-1425, its first-in-class selective retinoic acid receptor alpha (RARα) agon...

Epistem announces collaboration with Sanofi Aventis

Epistem plc, the UK biotechnology and personalised medicine company today announced a collaboration with sanofi-aventis U.S. Inc. relating to the use of Epistem's proprietary biomarker gene expression profiling and immunohistochemistry technologies. Under the terms of the agreement sanofi-aventis has entered into a 3 year collaboration with Epistem to provide discovery through to clinical biomarke...


Philips Launches Informatics Platform to Advance Drug Research & Biomarker Discovery

Today, Philips has announced the launch of Xplore, a web-based image and data management platform that will help pharma and academic researchers speed up drug research and biomarker discovery through enhanced integration, visualization and analytics tools. Xplore v4.0 will be available commercially in July 2017. Customers have the option to purchase the basic package or ... Read More

Mining health data for better patient outcomes: CBmed

The complexity and diversity of biomarker data makes it difficult to realize their full potential, but new innovations are making it easier to collect, integrate and analyze data for biomarker discovery.

Denovo Biomarkers: Robert Little. Providing a novel biomarker solution to personalize drug development

Robert Little, the Chief Business Officer of Denovo Biomarkers reveals to Fintan Walton the use of its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.

A Biomarker for CTE Could Make Living Diagnosis Possible

The discovery of a biomarker for chronic traumatic encephalopathy (CTE) could lead to diagnosis of the disease in living individuals, something not currently possible. CTE is a neurodegenerative brain disease thought to be caused by repeated blows to the head, resulting in brain damage that accumulates over time. A recent study of 111 NFL players who donated their brains after death found CTE i...

Hemispherx Encouraged By Cytokine Biomarker Discovery Which May Lead To A Diagnostic For Chronic Fatigue Syndrome

  Life Sciences Jobs   ...

STAT Plus: Biomarker

If it’s a function of, or it’s expressed in the human body and it can be measured, it can be a biomarker.

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

Insilico Medicine, a Baltimore-based leader in artificial intelligence for drug discovery and biomarker development, is pleased to announce a multi-year drug development agreement with the biotechnology company Juvenescence AI Limited.

Biomarker May Help Monitor MPS Disease Progression

Researchers have identified spermine as a potential biomarker associated with neuropathic forms of mucopolysaccharidoses (MPS), a family of rare metabolic...

Human Longevity Announces Agreement With Merck KGaA, Darmstadt, Germany To Engage In Cancer Biomarker Discovery In Advanced Melanoma

  Life Sciences Jobs   ...

Quantitating Glycans for Biomarker Discovery

Techniques for comparing the relative abundances of glycans and glycoproteins in clinical samples

Parkinsons Disease: The Search for Biomarkers

The Scientist is bringing together a panel of experts to share their experience with biomarker discovery and validation for Parkinson's Disease.

MedGenome raises $30mm in Series C financing round

MedGenome Labs Pvt. Ltd. (diagnostics/genomics) raised $30mm in its Series C financing round led by Sequoia India and Sofina ...

North America DNA Sequencing Market Forecast 20172023 [Updated: 04012017] Prices from USD $1250

KEY FINDINGSEurope has the second largest market share of the DNA sequencing market. Factors, which favor growth of DNA sequencing market, are better healthcare infrastructure, awareness about latest technologies, major biotechnology companies being based in this region and government initiatives for increasing research and development. The global DNA sequencing market is poised to grow during the...

The Human Epilepsy Project

Dr. Loeb summarizes a global and one-of-a-kind approach of biomarker and drug discovery using systems biology of human brain tissues.

BioMarker Strategies Announces Two New Patents Granted In Japan, Covering The Company???s Core Diagnostics Technologies For Solid Tumor Cancers

  Life Sciences Jobs   ...

NORTH AMERICA CANCER BIOMARKER MARKET FORECAST 20172025 [Report Updated: 16082017] Prices from USD $1250

KEY FINDINGSThe United States is a primary contributor to the North American cancer biomarker market, which is all set to expand with a CAGR of 13.17% between the forecasted years of 20172025. The market collections are also predicted to increase from $3748 million in 2016 to $11420 million by 2025.MARKET INSIGHTSThe market is mainly segmented into two segments: discovery diagnostics and diseases....

Europe DNA Sequencing Market Forecast 20172023 [Updated: 04012017] Prices from USD $1250

KEY FINDINGSAsiaPacific market is expected to report good growth in the forecast period due to higher awareness and demand for personalized medicine. Factors, which favor growth of DNA sequencing market, are better healthcare infrastructure, awareness about latest technologies, major biotechnology companies being based in this region and government initiatives for increasing research and developme...

Biomarker May Identify High-risk IgAN Patients

Gd-IgA1 level may represent a useful biomarker for risk stratification.

Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President CEO to Commercialize ...

"The Theralink technology represents a uniquely valuable and wholly complementary tumor biomarker strategy to various biomarker techniques currently in use, including DNA sequencing," said Dr. Read more...

EUROPE CANCER BIOMARKER MARKET FORECAST 20172025 [Report Updated: 16082017] Prices from USD $1250

KEY FINDINGSThe Europe cancer biomarker market is poised to grow at a CAGR of 13.46% for the years 20172025. The total income generated by the market is also predicted to increase to up to $8646 million by the end of this forecast period.MARKET INSIGHTSThe European market has a huge opportunity to grow in personalized medication on account of the support generated for the biomarkers test, growing ...

Imaging Biomarker Market: By Technology Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography and SinglePhoton Emission Computed Tomography, By Applications By RegionForecast 20162021 [Updated: 23022016] Prices from US

An imaging biomarker is used as a diagnostic mechanism which can be detected through an imaging technology. A biomarker is a biological molecule found in tissue, blood or other body fluids, which mark the presence of a normal or an abnormal process, or of a condition or disease. Thus, these biomarkers are used to monitor responses of the body to a disease. It can also be used for early detection o...

Milimeter-wave technologies, the promise of 5G wireless communications

(IMDEA Networks Institute) IMDEA Networks and Huawei Technologies have recently launched a joint research project to explore the synergies of two distinctive wireless technologies, which are both key components of the present and future of mobile communications. Their combination is crucial to enable the evolution of mobile networks, one of the most impactful technologies driving change and progre...


Quick Search
Advertisement
 

News Quicklinks